Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Hims & Hers Health Inc shares valued at $70,056 were sold by Boughton Soleil on Nov 26 ’24. At $29.90 per share, Boughton Soleil sold 2,343 shares. The insider’s holdings dropped to 165,254 shares worth approximately $5.01 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Okupe Oluyemi sold 101,993 shares, netting a total of over 3,021,496 in proceeds. Following the sale of shares at $29.62 each, the insider now holds 109,392 shares.
Before that, Chi Michael had sold 17,303 shares from its account. In a trade valued at $458,356, the Chief Commercial Officer traded Hims & Hers Health Inc shares for $26.49 each. Upon closing the transaction, the insider’s holdings decreased to 17,303 shares, worth approximately $5.61 million.
As published in a research note from BofA Securities on November 14, 2024, Hims & Hers Health Inc [HIMS] has been rated down from a Buy to an Underperform. Analysts at Needham started covering the stock with ‘”a Buy”‘ outlook in a report released in late August. As of August 09, 2024, Imperial Capital has decreased its “an Outperform” rating to a “an In-line” for HIMS. Earlier on May 22, 2024, Citigroup downgraded its rating. Their new recommendation was “a Neutral” for HIMS stock which previously was a “a Buy”.
Analyzing HIMS Stock Performance
During the last five days, there has been a surge of approximately 39.24%. Over the course of the year, Hims & Hers Health Inc shares have jumped approximately 240.90%. Shares of the company reached a 52-week high of $35.02 on 11/27/24 and a 52-week low of $8.09 on 01/05/24. A 50-day SMA is recorded $21.42, while a 200-day SMA reached $17.74. Nevertheless, trading volume fell to 24.64 million shares from 49.4 million shares the previous day.
Support And Resistance Levels for Hims & Hers Health Inc (HIMS)
According to the 24-hour chart, there is a support level at 28.57, which, if violated, would cause prices to drop to 26.81. In the upper region, resistance lies at 33.56. The next price resistance is at 36.79. RSI (Relative Strength Index) is 63.89 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 5.51, which suggests the price will increase in the coming days. Percent R is at 29.49%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
